BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 18304885)

  • 21. Pancreatic head resection with segmental duodenectomy: safety and long-term results.
    Nakao A; Fernández-Cruz L
    Ann Surg; 2007 Dec; 246(6):923-8; discussion 929-31. PubMed ID: 18043093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The carcinoembryonic antigen level in pancreatic juice and mural nodule size are predictors of malignancy for branch duct type intraductal papillary mucinous neoplasms of the pancreas.
    Hirono S; Tani M; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
    Ann Surg; 2012 Mar; 255(3):517-22. PubMed ID: 22301608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors.
    Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H
    Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant transformation of branch duct-type intraductal papillary mucinous neoplasms of the pancreas based on contrast-enhanced endoscopic ultrasonography morphological changes: focus on malignant transformation of intraductal papillary mucinous neoplasm itself.
    Ohno E; Itoh A; Kawashima H; Ishikawa T; Matsubara H; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
    Pancreas; 2012 Aug; 41(6):855-62. PubMed ID: 22481289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasms.
    Sawai Y; Yamao K; Bhatia V; Chiba T; Mizuno N; Sawaki A; Takahashi K; Tajika M; Shimizu Y; Yatabe Y; Yanagisawa A
    Endoscopy; 2010 Dec; 42(12):1077-84. PubMed ID: 21120776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathological features and medical management of intraductal papillary mucinous neoplasms.
    Okabayashi T; Kobayashi M; Nishimori I; Sugimoto T; Namikawa T; Okamoto K; Okamoto N; Kosaki T; Onishi S; Araki K
    J Gastroenterol Hepatol; 2006 Feb; 21(2):462-7. PubMed ID: 16509876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of branch-duct intraductal papillary mucinous neoplasms: a large single-center study to assess predictors of malignancy and long-term outcomes.
    Ridtitid W; DeWitt JM; Schmidt CM; Roch A; Stuart JS; Sherman S; Al-Haddad MA
    Gastrointest Endosc; 2016 Sep; 84(3):436-45. PubMed ID: 26905937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas.
    Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T
    Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intraductal papillary mucinous neoplasm of the pancreas: cytologic features predict histologic grade.
    Michaels PJ; Brachtel EF; Bounds BC; Brugge WR; Pitman MB
    Cancer; 2006 Jun; 108(3):163-73. PubMed ID: 16550572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mural nodule in branch duct-type intraductal papillary mucinous neoplasms of the pancreas is a marker of malignant transformation and indication for surgery.
    Akita H; Takeda Y; Hoshino H; Wada H; Kobayashi S; Marubashi S; Eguchi H; Tanemura M; Mori M; Doki Y; Nagano H
    Am J Surg; 2011 Aug; 202(2):214-9. PubMed ID: 21376305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pancreatic cancer in patients with pancreatic cystic lesions: a prospective study in 197 patients.
    Tada M; Kawabe T; Arizumi M; Togawa O; Matsubara S; Yamamoto N; Nakai Y; Sasahira N; Hirano K; Tsujino T; Tateishi K; Isayama H; Toda N; Yoshida H; Omata M
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1265-70. PubMed ID: 16979953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural history of branch duct intraductal papillary mucinous neoplasms of the pancreas: a multicenter study in Japan.
    Maguchi H; Tanno S; Mizuno N; Hanada K; Kobayashi G; Hatori T; Sadakari Y; Yamaguchi T; Tobita K; Doi R; Yanagisawa A; Tanaka M
    Pancreas; 2011 Apr; 40(3):364-70. PubMed ID: 21289527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differential diagnosis of benign or malignant intraductal papillary mucinous neoplasm of the pancreas by multidetector row helical computed tomography: evaluation of predictive factors by logistic regression analysis.
    Takeshita K; Kutomi K; Takada K; Haruyama T; Fukushima J; Aida R; Takada T; Furui S
    J Comput Assist Tomogr; 2008; 32(2):191-7. PubMed ID: 18379300
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term clinical and imaging follow-up of nonoperated branch duct form of intraductal papillary mucinous neoplasms of the pancreas.
    Arlix A; Bournet B; Otal P; Canevet G; Thevenot A; Kirzin S; Carrere N; Suc B; Moreau J; Escourrou J; Buscail L
    Pancreas; 2012 Mar; 41(2):295-301. PubMed ID: 21946814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal papillary-mucinous adenocarcinoma in the remnant pancreas after pancreatoduodenectomy for cancer of Vater's papilla associated with intraductal papillary-mucinous adenoma.
    Ishida M; Egawa S; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Furukawa T; Unno M
    J Hepatobiliary Pancreat Surg; 2007; 14(5):522-5. PubMed ID: 17909725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pylorus-preserving total pancreatectomy for an intraductal papillary-mucinous neoplasm of the pancreas.
    Inagaki M; Obara M; Kino S; Goto J; Suzuki S; Ishizaki A; Tanno S; Kohgo Y; Tokusashi Y; Miyokawa N; Kasai S
    J Hepatobiliary Pancreat Surg; 2007; 14(3):264-9. PubMed ID: 17520201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Appropriate indications of initial endoscopic ultrasound evaluation for detecting mural nodules in branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Kim YI; Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Hong EK
    Scand J Gastroenterol; 2013 May; 48(5):610-6. PubMed ID: 23597152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pancreatic main-duct involvement in branch-duct IPMNs: an underestimated risk.
    Fritz S; Klauss M; Bergmann F; Strobel O; Schneider L; Werner J; Hackert T; Büchler MW
    Ann Surg; 2014 Nov; 260(5):848-55; discussion 855-6. PubMed ID: 25379856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraductal papillary mucinous neoplasms of the pancreas.
    Gourgiotis S; Ridolfini MP; Germanos S
    Eur J Surg Oncol; 2007 Aug; 33(6):678-84. PubMed ID: 17207960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does a family history of pancreatic ductal adenocarcinoma and cyst size influence the follow-up strategy for intraductal papillary mucinous neoplasms of the pancreas?
    Mandai K; Uno K; Yasuda K
    Pancreas; 2014 Aug; 43(6):917-21. PubMed ID: 24743378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.